Just having a quick glance through the report.
How can they release to the market on 10/04/24 that 9 of 12 patients have been enrolled in the Open-Label MND extension study and expect the last 3 to be enrolled this month - when in actual fact one of the patients has died?
Seriously - this is misleading information!
The patient needs to be able to swallow to be able to continue in the trial. When did they cease to be able to swallow? Which site were they enrolled in?
Serious questions need some answers from the Company
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $78.76M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.0¢ | $57.71K | 349.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 71829 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 2606 | 1 |
View Market Depth
| Last trade - 15.31pm 15/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |